Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2016-03-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neonatal Non-Invasive Hemoglobin Determination
NCT01335919
Measurement of Total Hemoglobin by Pulse Oximetry in Neonatal Population
NCT03120702
Fetal Haemoglobin and Cerebral and Peripheral Oxygenation.
NCT04802629
Comparing Validity of Non-Invasive Hemoglobin Monitoring to Laboratory Results in Critically Ill Children
NCT01750463
The Effect of Blood Transfusion on Blood Flow to the Intestines of Premature Infants
NCT00167388
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hemoglobin measurement arm
In this arm hemoglobin measurement is done by four different devices
* device "Radical-7" for non-invasive measurement of SpHb
* device "HemoCue" for taking capillary and venous blood for measurement of HcHb
* device "ABL 800" for measurement of BGAHb
* device "Siemens ADVIA" for measurement of labHb
For measurement of haemoglobin by the devices the following interventions have to be done:
* venous or arterial puncture (routine)
* capillary puncture
* placing of the "Radical 7" sensor
hemoglobin measurement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hemoglobin measurement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\-
Exclusion Criteria
* medical or psychological factors that inhibit a correct finazilation of the study
3 Days
4 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johannes Gutenberg University Mainz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Eva Wittenmeier:MD
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Eva Wittenmeier
Mainz, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wittenmeier E, Lesmeister L, Pirlich N, Dette F, Schmidtmann I, Mildenberger E. Assessment of haemoglobin measurement by several methods - blood gas analyser, capillary and venous HemoCue(R) , non-invasive spectrophotometry and laboratory assay - in term and preterm infants. Anaesthesia. 2019 Feb;74(2):197-202. doi: 10.1111/anae.14481. Epub 2018 Nov 14.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Haemoglobin2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.